Cutaneous leukocytoclastic vasculitis associated with anti-tuberculosis drugs

Avcu G., Sensoy G., Celiksoy M. H., Sogut A., Kefeli M., Karli A., ...Daha Fazla

PEDIATRICS INTERNATIONAL, cilt.57, sa.1, ss.155-157, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 57 Sayı: 1
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1111/ped.12403
  • Dergi Adı: PEDIATRICS INTERNATIONAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.155-157
  • Anahtar Kelimeler: anti-tuberculosis drug, ethambutol, leukocytoclastic vasculitis, rifampicin, RIFAMPIN
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Leukocytoclastic vasculitis (LCV), a disease characterized by inflammation of the small vessels, presents with palpable purpura, especially in the lower extremities. Its etiology is known to include drugs, infection, collagen tissue disease, and malignancy, but LCV caused by anti-tuberculosis drugs is very rarely seen. This report describes the case of a 12-year-old girl who developed LCV with rifampicin and ethambutol while undergoing anti-tuberculosis treatment due to extensive pulmonary involvement.